GOLDMAN SACHS GROUP INC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 53 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$319,422
+25.8%
185,711
+42.6%
0.00%
Q2 2023$253,935
-66.9%
130,223
-52.8%
0.00%
Q1 2023$766,627
+78.0%
275,765
+120.9%
0.00%
Q4 2022$430,670
+35.0%
124,832
+0.6%
0.00%
Q3 2022$319,000
-15.6%
124,086
-20.5%
0.00%
Q2 2022$378,000
-68.3%
156,015
-46.2%
0.00%
Q1 2022$1,194,000
-79.0%
289,897
-34.4%
0.00%
-100.0%
Q4 2021$5,681,000
+736.7%
441,761
+603.2%
0.00%
Q3 2021$679,000
+121.2%
62,825
+86.6%
0.00%
Q2 2021$307,000
-65.0%
33,665
-63.8%
0.00%
Q1 2021$877,000
+492.6%
93,050
+147.2%
0.00%
Q4 2020$148,000
-25.3%
37,635
-49.8%
0.00%
Q3 2020$198,000
-22.0%
74,942
+95.6%
0.00%
Q2 2020$254,000
+84.1%
38,307
+61.6%
0.00%
Q1 2020$138,000
-45.2%
23,711
-15.7%
0.00%
Q4 2019$252,000
+113.6%
28,122
+105.0%
0.00%
Q3 2019$118,000
-6.3%
13,716
+21.1%
0.00%
Q2 2019$126,000
-97.0%
11,324
-96.2%
0.00%
-100.0%
Q3 2018$4,211,000295,7110.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders